Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Idcases|February 8, 2021
A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR systemYuki Yoshikawa, Michio Imamura, Kei Morio, et al.
Journal of Proteome Research|February 21, 2025
Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma DevelopmentHikaru Nakahara, Atsushi Ono, C Nelson Hayes, et al.
The Journal of Infectious Diseases|February 28, 2022
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAILYosuke Suehiro, Masataka Tsuge, Mio Kurihara, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirinEisuke Murakami, Michio Imamura, C Nelson Hayes, et al.
Antiviral Therapy|June 2, 2018
Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot studyYumiko Tatsukawa, Masataka Tsuge, Yoshiiku Kawakami, et al.
Biochemical and Biophysical Research Communications|October 22, 2013
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infectionsKeiichi Kosaka, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Gastroenterology and Hepatology|December 16, 2020
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinomaKenji Yamaoka, Kenichiro Kodama, Akira Hiramatsu, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosineAdrian S Ray, Brenda I Hernandez-Santiago, Judy S Mathew, et al.
Clinical Journal of Gastroenterology|February 6, 2020
Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instabilityYuwa Ando, Masami Yamauchi, Yosuke Suehiro, et al.
Yonago Acta Medica|November 29, 2023
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention TrialKensuke Naruto, Tomokazu Kawaoka, Shintaro Yamasaki, et al.
Pageof 20